Fenugreek
Real blood sugar data at food-level doses; the testosterone claim does not hold up when its trials are pooled.
C+
Evidence grade
C+
Worth it
$10-15/month
Typical cost
DoseThe blood sugar trials used seed powder at 5 g/day or more, in some trials considerably more, taken with meals; the 2020 update found the glycemic effects concentrated at those food-level doses. The testosterone trials used 600 mg/day of a branded seed extract. A 500 mg capsule of generic extract matches neither literature well.
BasisThe blood sugar claim has a real trial base with a consistent shape: a 2014 meta-analysis of 10 controlled trials (1,173 people) found fenugreek seed lowered fasting glucose by about 0.96 mmol/L (about 17 mg/dL) and post-meal glucose by about 2.2 mmol/L, with HbA1c down roughly 0.85 percentage points over 8 to 24 weeks, and a 2020 update found the effects concentrated at 5 g/day or more of seed powder.
Fenugreek is a legume seed, used as a spice and sold as a supplement, bought mostly for blood sugar and for testosterone. We grade Fenugreek C+ on evidence and C+ for worth-it at about $10-15 per month.
What it does
Fenugreek is a legume seed, used as a spice and sold as a supplement, bought mostly for blood sugar and for testosterone. The seed is rich in galactomannan fiber, which slows glucose absorption after a meal, and in saponins, the compounds the testosterone extracts are standardized for. The two markets buy different products at different doses: the blood sugar trials mostly fed grams of seed powder, while the testosterone trials use a few hundred milligrams of a branded extract, so neither literature answers for the other's product.
What the research says
Lowers blood sugar in type 2 diabetes
Evidence: emerging. A 2014 meta-analysis of 10 controlled trials (1,173 people) found fasting glucose down about 0.96 mmol/L (about 17 mg/dL), post-meal glucose down about 2.2 mmol/L, and HbA1c down roughly 0.85 percentage points over 8 to 24 weeks; a 2020 update found the effects concentrated at 5 g/day or more of seed powder. The trials are small and heterogeneous, and the studied form is seed powder at food doses.
Raises testosterone (the popular claim)
Evidence: weak. The supporting trials are small and maker-funded, testing branded extracts (Testofen at 600 mg/day; Rao 2016, 120 men aged 43 to 70, 12 weeks, is the best known). One 2020 pooling of four such trials found total testosterone higher by about 1.6 nmol/L; a separate pooled analysis of seven trials found no significant difference from placebo. Libido scores move more consistently than the hormone does, and no trial shows a strength, muscle, or fertility outcome.
Increases milk production during breastfeeding
Evidence: weak. Carried as unproven: a 2018 review of five randomized trials found two positive and three null, with low quality throughout.
The blood sugar claim has a real trial base with a consistent shape: a 2014 meta-analysis of 10 controlled trials (1,173 people) found fenugreek seed lowered fasting glucose by about 0.96 mmol/L (about 17 mg/dL) and post-meal glucose by about 2.2 mmol/L, with HbA1c down roughly 0.85 percentage points over 8 to 24 weeks, and a 2020 update found the effects concentrated at 5 g/day or more of seed powder. The caps are the base itself: small trials, high heterogeneity, mostly in diabetes populations, at food-level doses capsule products do not match. The testosterone claim is weaker (small maker-funded extract trials, one pooled analysis modestly positive, a separate pooling of seven trials null), and the lactation claim is unproven. The headline grade sits on the blood sugar half.
Is it worth it?
Evidence (C+) sits below the evidence bar for the ranking, which caps the worth-it grade at C+ however it is priced; the derived value at about $12 a month lands at C+. The studied form is seed powder at food doses, which is also the cheap form; the expensive branded extracts carry the weaker of the record's two claims.
Typical cost
$10-15/month
Common form, not a brand recommendation
Dosage context emerging
The blood sugar trials used seed powder at 5 g/day or more, in some trials considerably more, taken with meals; the 2020 update found the glycemic effects concentrated at those food-level doses. The testosterone trials used 600 mg/day of a branded seed extract. A 500 mg capsule of generic extract matches neither literature well.
The worth-it ranking
Fenugreek sits outside the worth-it ranking of 38.
Fenugreek sits outside that ranking of 38. The leaders below clear an evidence floor of B- before price counts at all, so cheap alone never earns a rank.
- 1AWorth itCreatine evidence A-~$5-10/mo
- 2AWorth itCaffeine evidence B+~$5-10/mo
- 3AWorth itVitamin D evidence B~$5-8/mo
When the evidence moves a grade, this ranking moves with it. Thursday is where you hear it first.
Safety notes
The common costs are gastrointestinal effects and a maple syrup body odor from the seed's sotolon. The cautions that matter: fenugreek can add to the glucose-lowering effect of sulfonylureas and insulin, it carries a warfarin caution, it is a legume-family allergen, and it is contraindicated in pregnancy (uterine stimulation in animal data). Talk to your doctor. This page is information, not medical advice.
Longevity Lab Report
The week's longevity and biohacking news.
Every story graded against the evidence. Free. Unsubscribe anytime.
Changelog
Last updated 2026-11-03
- 2026-11-03|Initial grading: Research's weekly deep dive of 2026-11-02 (fenugreek section), integrated on its dated queue slot (combined grading-order ruling: Tue Nov 3). Evidence C+ on the blood sugar half; the testosterone claim graded weak inside the record rather than allowed to borrow the metabolic grade; pregnancy contraindication and the diabetes-drug interaction stated in the record.
The week's longevity and biohacking news.
Every story graded against the evidence. Free. Unsubscribe anytime.
The week's longevity and biohacking news. Every story graded against the evidence. Free. Unsubscribe anytime.
Every grade follows a published rubric, and sponsors never change one. When the evidence moves a grade, Thursday is where you hear it first, before you renew a stack that stopped earning its cost.